Stock Comparison
ASND vs VRTX
Ascendis Pharma AS and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$17.10B
$124.70B
P/E (TTM)
30.3
29.2
Forward P/E
16.2
25.8
Price/Sales
19.8
10.2
Price/Book
30.9
6.4
EV/EBITDA
-20.8
24.0
Dividend Yield
—
—
Profitability
Net Margin
57.30%
35.50%
Operating Margin
10.10%
38.10%
Return on Equity
33.30%
24.20%
Return on Assets
-0.60%
12.10%
Growth (YoY)
Revenue Growth
144.30%
7.80%
Earnings Growth
0.00%
61.40%
Price & Risk
Beta
0.5
0.3
52-Week High
$271.89
$507.92
52-Week Low
$160.86
$362.50
Analyst Target
$291.15
$548.69
Compare ASND and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.